Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 7, 2008; 14(17): 2731-2739
Published online May 7, 2008. doi: 10.3748/wjg.14.2731
Published online May 7, 2008. doi: 10.3748/wjg.14.2731
CO, healthy control group | CI, untreated cirrhotic group | CI + IGF, cirrhotic rats treated with IGF-I | |
I-NADH-ubiquinone oxidoreductase (nmol/min per mg prot) | 7.68 ± 2.19 | 11.01 ± 1.60c | 16.10 ± 2.03 |
II-Succinate-ubiquinone oxidoreductase (&mgr;mol/min per mg prot) | 0.38 ± 0.02 | 0.33 ± 0.04 | 0.35 ± 0.03 |
III-Ubiquinol-ferricytochrome oxidoreductase (nmol/min per mg prot) | 89.57 ± 6.54 | 148.75 ± 23.26a | 163.15 ± 21.38b |
IV-Ferrocytochrome c-oxygen oxidoreductase (pmol/min per mg prot) | 3.91 ± 0.85 | 5.22 ± 1.01 | 5.66 ± 0.97 |
- Citation: Pérez R, García-Fernández M, Díaz-Sánchez M, Puche JE, Delgado G, Conchillo M, Muntané J, Castilla-Cortázar I. Mitochondrial protection by low doses of insulin-like growth factor-Iin experimental cirrhosis. World J Gastroenterol 2008; 14(17): 2731-2739
- URL: https://www.wjgnet.com/1007-9327/full/v14/i17/2731.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.2731